Clinical Trial Update: Health Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist Therapy

View source ↗

Summary

A completed clinical trial update evaluating health-related quality of life and multidimensional outcomes in men aged 60 years and older with prostate cancer in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Zoladex (goserelin)

Snippet

Sponsor: Ipsen | Conditions: Prostate Cancer | Status: COMPLETED